This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
22 Feb 2013 | Global | Market Research
Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
Financial Management is the Key Strategy for Sustainability
This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...
$4,950.00 -
22 Feb 2013 | Global | Market Research
Overview of the Global Systemic Lupus Erythematosus Pipeline and the Next Three Potential Product Launches
This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.
$1,500.00 -
12 Feb 2013 | Global | Market Research
Analysis of the Paediatric Vaccines Market in Ethiopia, Tanzania, and Uganda
This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers How will Consumers Fare?, and Illumina's acquisition of GenoLogics.
$1,500.00 -
25 Jan 2013 | Global | Market Research
GIL-100 Sales and Investment Attractiveness Index for Healthcare
Country Attractiveness for Healthcare
Where should one invest or sell in the aftermath of the financial crisis of 2008 and the on-going European debt crisis? While rich countries have shown very slow growth rates, emerging markets have shown much greater resilience. To increase profitability, you can either find new markets to increase sales, or seek opportunities to invest. Emerging ...
$1,500.00
